المؤلفون: Sara Jaafar, Alain Lescoat, Suiyuan Huang, Jessica Gordon, Monique Hinchcliff, Ami A. Shah, Shervin Assassi, Robyn Domsic, Elana J. Bernstein, Virginia Steen, Sabrina Elliott, Faye Hant, Flavia V. Castelino, Victoria K. Shanmugam, Chase Correia, John Varga, Vivek Nagaraja, David Roofeh, Tracy Frech, Dinesh Khanna

المصدر: Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-15 (2021)

مصطلحات موضوعية: Systemic sclerosis, Scleroderma, Diffuse cutaneous systemic sclerosis, Mortality, Survival, Interstitial lung disease, Diseases of the musculoskeletal system, RC925-935

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1478-6362Test

الوصول الحر: https://doaj.org/article/c2993868c861491d95f5c7bf680def8aTest

المؤلفون: Maya H Buch, John D Pauling, Michael Hughes, Alain Lescoat, David Roofeh, Whitney Townsend, Robert D Sandler, François Zimmermann

المصدر: BMJ Open, Vol 11, Iss 3 (2021)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

العلاقة: https://bmjopen.bmj.com/content/11/3/e044765.fullTest; https://doaj.org/toc/2044-6055Test

الوصول الحر: https://doaj.org/article/d806a9fec068477f9eb7837228589044Test

المؤلفون: Ahmad Ramahi, Alain Lescoat, David Roofeh, Vivek Nagaraja, Rajaie Namas, Suiyuan Huang, John Varga, David O’Dwyer, Bonnie Wang, Kevin Flaherty, Ella Kazerooni, Dinesh Khanna

المساهمون: University of Michigan [Ann Arbor], University of Michigan System, École des Hautes Études en Santé Publique [EHESP] (EHESP), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

المصدر: Rheumatology
Rheumatology, 2022, ⟨10.1093/rheumatology/keac639⟩

مصطلحات موضوعية: pulmonary function test, Rheumatology, [SDV]Life Sciences [q-bio], Interstitial lung disease, Pharmacology (medical), Systemic Sclerosis, Anti-topoisomerase I

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f01fb2cd0520f57137c139a56ae6677Test
https://doi.org/10.1093/rheumatology/keac639Test

المؤلفون: Alain Lescoat, Robert D Sandler, François Zimmermann, David Roofeh, Michael Hughes, John D Pauling, Susan L Murphy, Yen T Chen, Whitney Townsend, Maya H Buch, Dinesh Khanna

المساهمون: Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], École des Hautes Études en Santé Publique [EHESP] (EHESP), University of Sheffield [Sheffield], University of Michigan [Ann Arbor], University of Michigan System, Royal United Hospitals Bath (RUH), University of Manchester [Manchester]

المصدر: Rheumatology (Oxford)
Rheumatology
Rheumatology, 2022, ⟨10.1093/rheumatology/keac049⟩

مصطلحات موضوعية: combined response index, Scleroderma, Systemic, outcome measure, [SDV]Life Sciences [q-bio], domain, limited cutaneous systemic sclerosis, Article, Rheumatology, Scleroderma, Limited, Outcome Assessment, Health Care, Scleroderma, Diffuse, Quality of Life, Humans, scleroderma, Pharmacology (medical), Reactive Oxygen Species

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd47c06c9fd98f42f35dc58297adc15Test
https://doi.org/10.1093/rheumatology/keac049Test

المؤلفون: Joshua J Solomon, Vibeke Strand, Chester V. Oddis, Leticia Kawano-Dourado, Tracy J. Doyle, Jeffrey A. Sparks, Kevin K. Brown, Susanna Proudman, Athol U. Wells, Donald P. Tashkin, Dorcas E. Beaton, Dinesh Khanna, Whitney Townsend, Lara J Maxwell, Shaney L Barratt, James R. Seibold, Paul F. Dellaripa, Robert Vassallo, David Roofeh, Eric L. Matteson, Thomas Leonard, Robin Christensen

المصدر: Semin Arthritis Rheum
Roofeh, D, Barratt, S L, Wells, A U, Kawano-Dourado, L, Tashkin, D, Strand, V, Seibold, J, Proudman, S, Brown, K K, Dellaripa, P F, Doyle, T, Leonard, T, Matteson, E L, Oddis, C V, Solomon, J J, Sparks, J A, Vassallo, R, Maxwell, L, Beaton, D, Christensen, R, Townsend, W & Khanna, D 2021, ' Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease : A systematic review using the OMERACT filter 2.1 process ', Seminars in Arthritis and Rheumatism, vol. 51, no. 6, pp. 1331-1341 . https://doi.org/10.1016/j.semarthrit.2021.08.001Test

مصطلحات موضوعية: medicine.medical_specialty, Population, Outcome measures, Article, law.invention, Core set, FEV1/FVC ratio, Rheumatology, Randomized controlled trial, DLCO, law, Forced vital capacity, Humans, Medicine, education, Lung, education.field_of_study, Scleroderma, Systemic, business.industry, OMERACT, Reproducibility of Results, Construct validity, respiratory system, Diffusion capacity of carbon monoxide, Respiratory Function Tests, respiratory tract diseases, Clinical trial, Anesthesiology and Pain Medicine, Systematic review, Systemic sclerosis interstitial lung disease, Physical therapy, Observational study, Lung Diseases, Interstitial, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2143bc5443447d75f72bb9600b24f2a8Test
https://doi.org/10.1016/j.semarthrit.2021.08.001Test

المؤلفون: Grace Kim, Suiyuan Huang, David Roofeh, Dinesh Khanna, Christopher P. Denton, Celia J. F. Lin, Jonathan G. Goldin, Daniel E. Furst, focuSSced Investigators

المصدر: Arthritis Rheumatol

مصطلحات موضوعية: Adult, Male, Spirometry, medicine.medical_specialty, Vital capacity, Vital Capacity, Immunology, Antibodies, Monoclonal, Humanized, Placebo, Severity of Illness Index, Gastroenterology, Article, law.invention, 03 medical and health sciences, chemistry.chemical_compound, FEV1/FVC ratio, 0302 clinical medicine, Tocilizumab, Rheumatology, Randomized controlled trial, law, Internal medicine, Severity of illness, Image Processing, Computer-Assisted, medicine, Humans, Immunology and Allergy, skin and connective tissue diseases, Lung, 030203 arthritis & rheumatology, Scleroderma, Systemic, medicine.diagnostic_test, business.industry, Interstitial lung disease, Middle Aged, respiratory system, medicine.disease, Fibrosis, respiratory tract diseases, Treatment Outcome, 030228 respiratory system, chemistry, Disease Progression, Female, Lung Diseases, Interstitial, Tomography, X-Ray Computed, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc56767bc4d49f5f6ac64fecd960222Test
https://doi.org/10.1002/art.41668Test

المؤلفون: David Roofeh, Alain Lescoat, Dinesh Khanna

المساهمون: University of Michigan [Ann Arbor], University of Michigan System, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

المصدر: Current Opinion in Rheumatology
Current Opinion in Rheumatology, 2021, 33 (3), pp.240-248. ⟨10.1097/BOR.0000000000000795⟩
Current Opinion in Rheumatology, Lippincott, Williams & Wilkins, 2021, 33 (3), pp.240-248. ⟨10.1097/BOR.0000000000000795⟩
Curr Opin Rheumatol

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Disease, Article, Scleroderma, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Tocilizumab, Rheumatology, Randomized controlled trial, law, Internal medicine, medicine, Humans, Lung transplantation, Disease management (health), Randomized Controlled Trials as Topic, 030203 arthritis & rheumatology, Scleroderma, Systemic, business.industry, Interstitial lung disease, respiratory system, medicine.disease, respiratory tract diseases, 3. Good health, 030104 developmental biology, chemistry, Nintedanib, Lung Diseases, Interstitial, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c51a53b2b2b8fdd0191ca11af5c8c3e3Test
https://doi.org/10.1097/bor.0000000000000795Test

المؤلفون: Alain Lescoat, Francesco Del Galdo, Peter A. Merkel, Dominique Godard, Michael Hughes, Sue Farrington, Susan L. Murphy, Virginia D. Steen, David Cella, John D Pauling, Dinesh Khanna, Rachel Wessel, Yannick Allanore, Christopher P. Denton, Robert D Sandler, David Roofeh, François Zimmermann, Lorinda Chung, Maya H. Buch, Whitney Townsend

المساهمون: Chard-Hutchinson, Xavier, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], University of Michigan [Ann Arbor], University of Michigan System, Royal United Hospitals Bath (RUH), School of Veterinary and Life Sciences [Murdoch], Murdoch University, Sheffield Children's NHS Foundation Trust, Stanford University, University College London Hospitals (UCLH), Hospital of the University of Pennsylvania (HUP), Perelman School of Medicine, University of Pennsylvania-University of Pennsylvania, Georgetown University Medical Center, Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Leeds, Association des Sclérodermie de France, Northwestern University Feinberg School of Medicine, Manchester Academic Health Science Centre (MAHSC), University of Manchester [Manchester], SRUK/WSF [UHUHR1], NIH/NIAMS 24 [AR063120], Y NIH/NIAMS T32 grant [AR007080], Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), University of Pennsylvania [Philadelphia]-University of Pennsylvania [Philadelphia]

المصدر: Journal of Scleroderma and Related Disorders
Journal of Scleroderma and Related Disorders, 2021, 6 (1), pp.66-76. ⟨10.1177/2397198320961967⟩
J Scleroderma Relat Disord

مصطلحات موضوعية: combined response index, medicine.medical_specialty, Treatment response, [SDV]Life Sciences [q-bio], media_common.quotation_subject, Immunology, limited cutaneous systemic sclerosis, classifications, Systemic scleroderma, Article, Scleroderma, law.invention, Neglect, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Randomized controlled trial, Quality of life, law, Immunology and Allergy, Medicine, scleroderma, 030212 general & internal medicine, Intensive care medicine, media_common, 030203 arthritis & rheumatology, integumentary system, business.industry, medicine.disease, 3. Good health, [SDV] Life Sciences [q-bio], Clinical trial, quality of life, Drug development, Systemic sclerosis, composite score, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::427662109927fd30c5af58fc49b4dc13Test
https://doi.org/10.1177/2397198320961967Test

المؤلفون: Alain Lescoat, David Roofeh, Dinesh Khanna

المساهمون: University of Michigan [Ann Arbor], University of Michigan System, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

المصدر: Expert Opinion on Emerging Drugs
Expert Opinion on Emerging Drugs, 2020, 25 (4), pp.455-466. ⟨10.1080/14728214.2020.1836156⟩
Expert Opin Emerg Drugs
Expert Opinion on Emerging Drugs, Informa Healthcare, 2020, 25 (4), pp.455-466. ⟨10.1080/14728214.2020.1836156⟩

مصطلحات موضوعية: Pathology, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Connective tissue, 030226 pharmacology & pharmacy, Article, Scleroderma, 03 medical and health sciences, 0302 clinical medicine, Animals, Humans, Medicine, Pharmacology (medical), Molecular Targeted Therapy, Precision Medicine, Pharmacology, Scleroderma, Systemic, business.industry, Mechanism (biology), medicine.disease, 3. Good health, emerging drugs, medicine.anatomical_structure, Underlying disease, phase 2, Drug Design, phase 3, 030220 oncology & carcinogenesis, Systemic sclerosis, business, Immunosuppressive Agents

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ff7be67b929ae9e71c64936f5f34e6Test
https://doi.org/10.1080/14728214.2020.1836156Test

المؤلفون: Elana J. Bernstein, Christopher P. Denton, Alain Lescoat, Dinesh Khanna, David Roofeh, Fernando J. Martinez, Ella A. Kazerooni, Kevin R. Flaherty, Michael D. Roth

المساهمون: Chard-Hutchinson, Xavier, University of Michigan [Ann Arbor], University of Michigan System, École des Hautes Études en Santé Publique [EHESP] (EHESP), Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Columbia University Irving Medical Center (CUIMC), University of California [Los Angeles] (UCLA), University of California (UC), Cornell University [New York], University College of London [London] (UCL), K23‐AR075112, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), University of California

المصدر: Arthritis and Rheumatology (hoboken, N.j.)
Arthritis and Rheumatology (hoboken, N.j.), 2022, 74 (1), pp.13-27. ⟨10.1002/art.41933⟩
Arthritis Rheumatol
Arthritis and Rheumatology (hoboken, N.j.), 2021, ⟨10.1002/art.41933⟩

مصطلحات موضوعية: Oncology, Indoles, [SDV]Life Sciences [q-bio], Disease, Scleroderma, Pulmonary function testing, chemistry.chemical_compound, 0302 clinical medicine, nintedanib, stem cell transplant, Immunology and Allergy, skin and connective tissue diseases, Drug Approval, interstitial lung disease, [SDV.MHEP.RSOA] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, integumentary system, Interstitial lung disease, respiratory system, 3. Good health, [SDV] Life Sciences [q-bio], [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Systemic sclerosis, Nintedanib, medicine.drug, medicine.medical_specialty, Cyclophosphamide, Immunology, Context (language use), Antibodies, Monoclonal, Humanized, Article, 03 medical and health sciences, tocilizumab, Tocilizumab, Rheumatology, Internal medicine, medicine, Humans, 030203 arthritis & rheumatology, Scleroderma, Systemic, business.industry, United States Food and Drug Administration, lung fibrosis, mycophenolate mofetil, medicine.disease, United States, 030228 respiratory system, chemistry, cyclophosphamide, business, Lung Diseases, Interstitial

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6ed323e0c4da75943aea02f973a2684Test
https://doi.org/10.1002/art.41933Test